Clinic
Wahid Medical Care, P.C
Wahid Medical Care, P.C was paid $11.94M by Medicaid between Jan 2018 and Nov 2024, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 84% of everything it billed.
33Billing provider infoWAHID MEDICAL CARE, P.C
BROOKLYN, NY 11228
BROOKLYN, NY 11228
33aNPI1154655439assigned 09/19/2009
33bProvider typeHealth Service Clinic/Center
28Total paid$11.94M
24GClaims300,604
24DCodes billed54
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Health Service Clinic/Center providers in New York
Rank by total paid#4 of 54
Median peer was paid$410K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,008 | $846K | |
| 2019 | 33,417 | $1.00M | |
| 2020 | 39,468 | $1.43M | |
| 2021 | 51,356 | $2.37M | |
| 2022 | 53,263 | $2.44M | |
| 2023 | 53,809 | $2.32M | |
| 2024incomplete | 37,283 | $1.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 84% | 143,629 | 84,356 | $10.03M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.7% | 4,530 | 4,460 | $441K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.1% | 4,139 | 4,092 | $371K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 12,125 | 9,690 | $218K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 1,942 | 1,902 | $173K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 3,749 | 3,630 | $142K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,270 | 1,227 | $107K |
| 99385 | <1% | 703 | 702 | $67K | |
| 99386 | <1% | 469 | 469 | $48K | |
| 86769 | <1% | 2,616 | 2,611 | $45K | |
| 81000 | <1% | 12,338 | 12,233 | $35K | |
| 90658 | <1% | 3,379 | 3,367 | $35K |
42 more codes
| 82042 | <1% | 10,470 | $35K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,752 | $33K |
| 93000 | <1% | 2,317 | $28K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,410 | $19K |
| 99397 | <1% | 157 | $14K | |
| 86580 | <1% | 3,234 | $14K | |
| 0031A | <1% | 369 | $13K | |
| 83700 | <1% | 11,529 | $12K | |
| 99384 | <1% | 112 | $9K | |
| 99383 | <1% | 108 | $9K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 6,770 | $8K |
| 82270 | <1% | 2,592 | $7K | |
| 90733 | <1% | 200 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 816 | $5K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 52 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,815 | $4K |
| 99382 | <1% | 30 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,774 | $2K |
| 90714 | <1% | 73 | $2K | |
| 90734 | <1% | 36 | $2K | |
| 82948 | <1% | 656 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 55 | $814.65 |
| 0011A | <1% | 19 | $660.78 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 43 | $624.24 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 194 | $613.08 |
| 0012A | <1% | 17 | $590.65 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,472 | $355.41 |
| 91303 | <1% | 365 | $280.00 | |
| 90716 | <1% | 28 | $210.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 266 | $119.08 |
| 99000 | <1% | 13,357 | $80.20 | |
| 90715 | <1% | 16 | $56.42 | |
| 90649 | <1% | 14 | $30.00 | |
| 87806 | <1% | 11,589 | $29.88 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 68 | $24.76 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,554 | $17.46 |
| 83006 | <1% | 140 | $15.19 | |
| 86023 | 0% | 165 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 91301 | 0% | 42 | $0.00 | |
| 94760 | 0% | 12 | $0.00 | |
| 90634 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWAHID, ABDUL (PRESIDENT)